BioSpace News Archive

Neurotrope, Inc. (Nasdaq: NTRP), a clinical- stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases, including Alzheimer’s disease (“AD”) is announcing that Dr. Daniel L. Alkon, the Company’s President and CSO, will be honored among the recipients of the Cure Coin Award

Dr. Joseph Kravitz is prosthodontist who comprehensively diagnoses and treats the dental health needs of patients and offers minimally invasive treatment procedures that involve incredibly low levels of pain and discomfort for dental patients

Keystone Heart Ltd. today announced that it has signed a distribution agreement with Ireland-based Vasorum Ltd. for sales and marketing of their Celt ACD® Vascular Closure Device.

− Announces Planned Appointment of Jeff Poulton − Manmeet S. Soni to Resign After a Transition Period

DionyMed Further Strengthens its Brand Portfolio with Premium Cannabis Edibles Brand in Northern California

Gilead will provide funding to Renown IHI to sequence and analyze the DNA of 15,000 individuals living with NASH or nonalcoholic fatty liver disease (NAFLD) as well as a control cohort of 40,000 individuals in Nevada.

HeartCare Imaging, a leading provider of high-impact management solutions and diagnostic imaging services, has been selected by Healthcare Tech Outlook as Top 10 Medical Imaging Consulting/Services Companies in 2019!

The Centers for Disease Control and Prevention (CDC) estimates that approximately 300,000 people will be infected with Lyme disease each year in the United States.

Biosimilars have the potential to realize billions in savings for the health care system if reforms are enacted to incent their market share to grow, according to a new issue brief issued by the Center for Medical Economics and Innovation at the California-based, free-market think tank, the Pacific Research Institute.

New research from Parks Associates reveals 15% of US broadband households have used a telecare service in the past 12 months.